Search
for
Sort by
Research 451–480 of 1000+
- Synthesis and biological evaluation of esters of 16-formyl-17-methoxy-dehydroepiandrosterone derivatives as inhibitors of 5α-reductase type 2
- Platelet GPIIb/IIIa (P1A1/2) polymorphism in SLE: clinical and laboratory association
- 62823 Optimization of deuruxolitinib dosing in adult patients with alopecia areata: Results from a randomized, parallel-group, multicenter, Phase 2 trial
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- The most common skin symptoms in young adults and adults related to SARS-CoV-2 virus infection
- Long COVID-19 Effects (Chronic Covid-19 syndrome) in Nepalese Cohort recovered from SARS-CoV-2 infection
- SARS-CoV-2 vaccination complicated by small fiber neuropathy, mast cell activation syndrome, and pericarditis
- SARS-CoV-2-induced Host Metabolic Reprogram (HMR): Nutritional Interventions for Global Management of COVID-19 and Post-Acute Sequelae of COVID-19 (PASC)
- Efficacy of 2.5 mg oral biotin versus 5% topical minoxidil in increasing nail growth rate
- Telogen effluvium in the new SARS‐CoV‐2 era
- Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Minoxidil Acts as an Antiandrogen: A Study of 5α-reductase Type 2 Gene Expression in a Human Keratinocyte Cell Line.
- The oestrogen receptor 2 (<i>ESR2</i>) gene in female-pattern hair loss: replication of association with rs10137185 in German patients
- De novo follicular regeneration of the skin by wingless int 3 and bone morphogenetic protein 2 genes introduced into dermal fibroblasts and fibroblast growth factor‐2 protein
- Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2
- Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
- Ultrastructural evidence for anagen hair follicle infection with SARS‐CoV‐2 in early‐onset COVID‐19 effluvium
- Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination
- Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
- Intra-host SARS-CoV-2 single-nucleotide variants emerged during the early stage of COVID-19 pandemic forecast population fixing mutations
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
- Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
- Poly(rC) binding protein 2 acts as a negative regulator of IRES-mediated translation of Hr mRNA
- A Super-Megassession of 2,800 to 4,000 Follicular Units, Packed to 40–50 FUs/cm<sup>2</sup>: Are You Prepared?
- Effects of 2-Ethylhexanoic Acid on Reproduction and Postnatal Development in Wistar Rats
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Normoglycemia and type 2 diabetes: exploring secreted frizzled-4, insulin resistance, and waist-height ratio